Hello. I'm Omar Usmani.
I'm a Reader in Respiratory Medicine at
Imperial College London and a Consultant Physician at the Royal Brompton Hospital.
I'm going to be talking about updates in Chronic Obstructive Pulmonary Disease, COPD,
particularly those in the last two years that have had an influence on
our clinical practice and may also help us guide research in the future years.
And this is my faculty disclosure and I wanted to emphasize that I have
no shares in any of the company and I have
no relationship of any kind with the tobacco industry.
So, I will review the anatomy and the pathology,
and how that relates to the physiology and importantly,
how that determines our management and treatment and
pharmacological approach of patients with COPD in the clinic.
So, I will review five key areas: clinical characteristics,
the Pathophysiology of patients with COPD,
how we're assessing the lungs and novel methods of assessing
the lungs that have appeared over the last few years,
the new disease classifications we have seen particularly this year, and also,
how that reflects on our new approach to
the therapeutic management of patients with COPD.